Gary Gilkeson to Nitric Oxide Synthase
This is a "connection" page, showing publications Gary Gilkeson has written about Nitric Oxide Synthase.
Connection Strength
1.461
-
The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol. 2006 Dec; 121(3):243-50.
Score: 0.258
-
Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J Pharmacol Exp Ther. 2005 Jan; 312(1):69-76.
Score: 0.226
-
Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. J Rheumatol. 2004 Sep; 31(9):1756-62.
Score: 0.226
-
Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans. J Rheumatol. 2003 Jan; 30(1):60-7.
Score: 0.201
-
Prostaglandin J(2) inhibition of mesangial cell iNOS expression. Clin Immunol. 2001 Mar; 98(3):337-45.
Score: 0.177
-
Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med. 1997 Aug 04; 186(3):365-73.
Score: 0.138
-
A novel PPAR response element in the murine iNOS promoter. Mol Immunol. 2005 Jul; 42(11):1303-10.
Score: 0.058
-
Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol. 2000 Feb 01; 164(3):1498-504.
Score: 0.041
-
Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999 Nov-Dec; 111(6):611-21.
Score: 0.040
-
Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol. 1997 Apr; 83(1):86-92.
Score: 0.034
-
Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med. 1996 Sep 01; 184(3):1173-8.
Score: 0.032
-
The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med. 1994 Feb 01; 179(2):651-60.
Score: 0.027